![]() Back to Annual Meeting
|
|
![]() Back to Annual Meeting
|
APHA Scientific Session and Event Listing |
Steffany Haaz, MFA, Chethan Ram Kasargod Prabhakar, MBBS, and Susan J. Bartlett, PhD. Division of Rheumatology, Johns Hopkins University, 5501 Hopkins-Bayview Circle, 1B.14, Baltimore, MD 21224, 410-550-5216, shaaz@jhsph.edu
Rheumatoid arthritis (RA) is a chronic, painful disease resulting in disability, difficulty with activities and poor quality of life (QOL). Exercise is recommended to reduce symptoms, slow progression and decrease muscle wasting. Unfortunately, most RA patients are sedentary. Yoga is an ancient Indian form including physical poses, deep breathing, relaxation and meditation, which may benefit RA patients. This is a small RCT (N=40) of an 8-week yoga intervention. Inclusion criteria are: age 18 or older, RA diagnosis, sedentary but able to exercise, stable disease for 6 months, no use of assistive devices for walking, and no co-morbid conditions with similar symptoms. Participants are randomized to immediate treatment or waitlist control. The intervention includes 2 hour-long classes per week and one hour of home practice. Outcomes are measured at baseline, midpoint, end of classes and 6 months later. These include QOL, physical fitness, psychological wellbeing and disease activity. Baseline data is available for 31 patients. Eleven have completed intervention (6) or control (5). At baseline, RA patients had lower QOL than healthy norms, especially for physical domains. After 8 weeks of yoga, the intervention group improved on all impaired domains, compared to controls (p<.05). Other outcomes have not yet been assessed. Although this data is based only on the first cohort, yoga shows promise for improving QOL in patients with RA. Further investigation is necessary to determine the sustainability of these benefits.
Learning Objectives:
Keywords: Physical Activity, Arthritis
Presenting author's disclosure statement:
Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
The 135th APHA Annual Meeting & Exposition (November 3-7, 2007) of APHA